Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

United Health Products (UEEC) Cash & Current Investments (2016 - 2025)

United Health Products' Cash & Current Investments history spans 14 years, with the latest figure at $65249.0 for Q4 2025.

  • Quarterly results put Cash & Current Investments at $65249.0 for Q4 2025, down 61.36% from a year ago — trailing twelve months through Dec 2025 was $65249.0 (down 61.36% YoY), and the annual figure for FY2025 was $65249.0, down 61.36%.
  • Cash & Current Investments for Q4 2025 was $65249.0 at United Health Products, up from $18376.0 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $170588.0 in Q1 2021 to a low of $225.0 in Q2 2025.
  • The 5-year median for Cash & Current Investments is $38369.0 (2022), against an average of $62444.6.
  • The sharpest move saw Cash & Current Investments surged 2188.55% in 2021, then plummeted 98.8% in 2025.
  • Year by year, Cash & Current Investments stood at $21799.0 in 2021, then crashed by 38.63% to $13377.0 in 2022, then soared by 613.31% to $95420.0 in 2023, then soared by 76.99% to $168883.0 in 2024, then plummeted by 61.36% to $65249.0 in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $65249.0, $18376.0, and $225.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.